CUE logo

Cue Biopharma (CUE) Cash From Investing

Annual CFI

$25.00 M
+$49.61 M+201.59%

31 December 2023

CUE Cash From Investing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFI

$98.00 K
+$108.00 K+1080.00%

30 September 2024

CUE Quarterly CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFI

$33.00 K
-$4.90 M-99.33%

30 September 2024

CUE TTM CFI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CUE Cash From Investing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+201.6%-98.0%-99.9%
3 y3 years+461.1%+990.9%-99.8%
5 y5 years+222.8%-97.5%-99.9%

CUE Cash From Investing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+201.6%-99.3%+100.3%-99.9%+100.1%
5 y5 yearsat high+201.6%-99.3%+100.3%-99.9%+100.1%
alltimeall timeat high+201.6%-99.3%+100.3%-99.9%+100.1%

Cue Biopharma Cash From Investing History

DateAnnualQuarterlyTTM
Sept 2024
-
$98.00 K(-1080.0%)
$33.00 K(-99.3%)
June 2024
-
-$10.00 K(-81.8%)
$4.93 M(-50.4%)
Mar 2024
-
-$55.00 K(<-9900.0%)
$9.95 M(-60.2%)
Dec 2023
$25.00 M(-201.6%)
$0.00(-100.0%)
$25.00 M(-16.7%)
Sept 2023
-
$5.00 M(0.0%)
$30.00 M(-763.9%)
June 2023
-
$5.00 M(-66.7%)
-$4.52 M(-52.8%)
Mar 2023
-
$15.00 M(+200.1%)
-$9.58 M(-61.1%)
Dec 2022
-$24.61 M(-370.2%)
$5.00 M(-116.9%)
-$24.61 M(-16.9%)
Sept 2022
-
-$29.52 M(>+9900.0%)
-$29.61 M(>+9900.0%)
June 2022
-
-$62.00 K(+129.6%)
-$99.50 K(-63.2%)
Mar 2022
-
-$27.00 K(-5500.0%)
-$270.50 K(-103.0%)
Dec 2021
$9.11 M(+104.4%)
$500.00(-104.5%)
$9.11 M(-52.1%)
Sept 2021
-
-$11.00 K(-95.3%)
$19.00 M(-19.7%)
June 2021
-
-$233.00 K(-102.5%)
$23.66 M(-0.4%)
Mar 2021
-
$9.35 M(-5.5%)
$23.76 M(+433.2%)
Dec 2020
$4.46 M
$9.89 M(+112.5%)
$4.46 M(-121.7%)
DateAnnualQuarterlyTTM
Sept 2020
-
$4.65 M(-3424.3%)
-$20.58 M(-3.2%)
June 2020
-
-$140.00 K(-98.6%)
-$21.25 M(+33.0%)
Mar 2020
-
-$9.95 M(-34.3%)
-$15.98 M(-563.7%)
Dec 2019
$3.45 M(-116.9%)
-$15.15 M(-480.2%)
$3.45 M(-85.2%)
Sept 2019
-
$3.98 M(-22.3%)
$23.28 M(-639.7%)
June 2019
-
$5.13 M(-45.9%)
-$4.31 M(-57.7%)
Mar 2019
-
$9.48 M(+102.3%)
-$10.20 M(-49.9%)
Dec 2018
-$20.35 M(+1589.1%)
$4.69 M(-119.9%)
-$20.35 M(-18.8%)
Sept 2018
-
-$23.61 M(+3006.3%)
-$25.06 M(+1409.6%)
June 2018
-
-$760.00 K(+12.9%)
-$1.66 M(+25.6%)
Mar 2018
-
-$673.00 K(+3442.1%)
-$1.32 M(+9.7%)
Dec 2017
-$1.21 M(+133.5%)
-$19.00 K(-90.9%)
-$1.21 M(+1.6%)
Sept 2017
-
-$208.00 K(-50.7%)
-$1.19 M(+21.3%)
June 2017
-
-$422.00 K(-24.1%)
-$978.00 K(+75.9%)
Mar 2017
-
-$556.00 K
-$556.00 K
Dec 2016
-$516.00 K(-35.8%)
-
-
Dec 2015
-$804.30 K
-
-

FAQ

  • What is Cue Biopharma annual cash flow from investing activities?
  • What is the all time high annual CFI for Cue Biopharma?
  • What is Cue Biopharma annual CFI year-on-year change?
  • What is Cue Biopharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Cue Biopharma?
  • What is Cue Biopharma quarterly CFI year-on-year change?
  • What is Cue Biopharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Cue Biopharma?
  • What is Cue Biopharma TTM CFI year-on-year change?

What is Cue Biopharma annual cash flow from investing activities?

The current annual CFI of CUE is $25.00 M

What is the all time high annual CFI for Cue Biopharma?

Cue Biopharma all-time high annual cash flow from investing activities is $25.00 M

What is Cue Biopharma annual CFI year-on-year change?

Over the past year, CUE annual cash flow from investing activities has changed by +$49.61 M (+201.59%)

What is Cue Biopharma quarterly cash flow from investing activities?

The current quarterly CFI of CUE is $98.00 K

What is the all time high quarterly CFI for Cue Biopharma?

Cue Biopharma all-time high quarterly cash flow from investing activities is $15.00 M

What is Cue Biopharma quarterly CFI year-on-year change?

Over the past year, CUE quarterly cash flow from investing activities has changed by -$4.90 M (-98.04%)

What is Cue Biopharma TTM cash flow from investing activities?

The current TTM CFI of CUE is $33.00 K

What is the all time high TTM CFI for Cue Biopharma?

Cue Biopharma all-time high TTM cash flow from investing activities is $30.00 M

What is Cue Biopharma TTM CFI year-on-year change?

Over the past year, CUE TTM cash flow from investing activities has changed by -$29.97 M (-99.89%)